Co-Diagnostics (0A50) Income Statement
Co-Diagnostics Income Statement
Last quarter (Q2 2026), Co-Diagnostics's total revenue was $166.13K, an increase of 1.98% from the same quarter last year. In Q2, Co-Diagnostics's net income was $-6.28M. See Co-Diagnostics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 622.49K | $ 3.92M | $ 6.81M | $ 34.22M | $ 97.89M | |
| $ 400.11K | $ 2.92M | $ 2.63M | $ 28.74M | $ 86.31M | |
| $ 31.68M | $ 43.00M | $ 45.33M | $ 55.72M | $ 40.25M | |
| Depreciation and Amortization | $ 1.11M | $ 1.38M | $ 1.23M | $ 1.28M | $ 335.36K |
| $ -47.41M | $ -36.20M | $ -36.88M | $ -10.31M | $ 45.97M | |
| $ -31.28M | $ -40.08M | $ -42.71M | $ -26.98M | $ 46.06M | |
| $ -17.23M | $ 2.50M | $ 4.60M | $ 8.13M | $ -429.16K | |
| $ -48.51M | $ -37.58M | $ -38.11M | $ -18.85M | $ 45.64M | |
| $ -46.90M | $ -37.64M | $ -35.33M | $ -14.24M | $ 36.66M | |
| Per Share Metrics | |||||
| Basic EPS | $ -35.25 | $ -37.20 | $ -36.00 | $ -13.50 | $ 38.10 |
| Diluted EPS | $ -35.25 | $ -37.20 | $ -36.00 | $ -13.50 | $ 36.90 |
| Weighted Average Shares Outstanding | 1.33M | 1.01M | 978.22K | 1.05M | 962.49K |
| Weighted Average Shares Outstanding (Diluted) | 1.33M | 1.01M | 978.22K | 1.05M | 996.79K |
Currency in USD